Changes in Patterns of Use of Advanced Therapies Following Emerging Data About Adverse Events in Patients With Rheumatoid Arthritis From the Veterans Affairs Health System

OBJECTIVE: To determine whether prescribing practices for Janus kinase inhibitors (JAKi), tumor necrosis factor inhibitors (TNFi), and non‐TNFi biologic agents changed after the results of the Oral Rheumatoid Arthritis Trial (ORAL) Surveillance trial were released in January 2021. METHODS: This is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Stephanie, George, Michael D., Mikuls, Ted R., England, Bryant R., Sauer, Brian, Cannon, Grant W., Baker, Joshua F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2023
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570666/
https://www.ncbi.nlm.nih.gov/pubmed/37658632
http://dx.doi.org/10.1002/acr2.11602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570666/
https://www.ncbi.nlm.nih.gov/pubmed/37658632
http://dx.doi.org/10.1002/acr2.11602

Ejemplares similares